electroCore, Inc. (NASDAQ: ECOR) is a commercial-stage medical technology enterprise. Purchasing ECOR stock provides fractional ownership in a company that designs, manufactures, and commercializes proprietary non-invasive vagus nerve stimulation (nVNS) therapies—such as the gammaCore device—targeted at treating primary headache disorders, migraine pain, cluster headaches, and select neurological conditions.